NEW YORK, Sept. 25, 2018 /PRNewswire/ -- Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a
national shareholder and consumer rights litigation firm, is notifying investors that a class action lawsuit has been filed
against Cocrystal Pharma, Inc. ("Cocrystal" or the "Company"), formerly known as BioZone Pharmaceuticals, Inc. ("BioZone")
(NASDAQ: COCP) and other defendants, related to alleged violations of federal securities laws. If you purchased
Cocrystal or BioZone securities between September 23, 2013 and September 7,
2018, you are encouraged to contact a Scott+Scott attorney at (844) 818-6982 for more information.
Cocrystal is a clinical stage biotechnology company that develops antiviral therapeutics that target the replication machinery
of hepatitis viruses, influenza viruses, and noroviruses.
The lawsuit alleges that defendants made false and/or misleading statements and/or failed to disclose that: (1) defendants
were engaged in a pump-and-dump scheme to artificially inflate Cocrystal's stock price; (2) this illicit scheme would result in
governmental scrutiny, including from the SEC; (3) defendants failed to abide by SEC disclosure regulations; and (4) as a result,
defendants' statements about Cocrystal's business, operations and prospects were materially false and misleading and/or lacked a
reasonable basis at all relevant times.
On September 7, 2018, the SEC issued a press release entitled "SEC Charges Microcap Fraudsters
for Roles in Lucrative Market Manipulation Schemes," which included Phillip Frost, a Director of
Cocrystal as a defendant.
What You Can Do
If you purchased Cocrystal or BioZone securities between September 23, 2013 and September 7, 2018, inclusive, or if you have questions about this notice, please contact attorney Joe Pettigrew at (844) 818-6982, or at jpettigrew@scott-scott.com. The lead plaintiff deadline is November 19,
2018.
About Scott+Scott Attorneys at Law LLP
Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions
throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide
with offices in New York, London, Connecticut, California, and Ohio.
Attorney Advertising
CONTACT:
Joe Pettigrew
Scott+Scott Attorneys at Law
LLP
230 Park Ave, 17 Fl, NY, NY 10169-1820
(844) 818-6982
jpettigrew@scott-scott.com
View original content:http://www.prnewswire.com/news-releases/scottscott-attorneys-at-law-llp-alerts-investors-to-the-filing-of-securities-class-action-against-cocrystal-pharma-inc-formerly-known-as-biozone-pharmaceuticals-inc-cocp-300718527.html
SOURCE Scott+Scott Attorneys at Law LLP